© Copyright - Newspaper WordPress Theme by TagDiv
Mefenamic Acid
Also known as / Synonyms: Mefenamic Acid, Fenamate NSAID, Dysmenorrhea Analgesic
Specialized gynecological NSAID that blocks uterine prostaglandins to stop painful menstrual cramps and reduce heavy period bleeding.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Treatment of primary dysmenorrhea (painful menstrual cramps and pelvic pain).
- Treatment of menorrhagia (excessive menstrual blood loss) secondary to ovulatory dysfunctional uterine bleeding or IUD usage.
- Relief of mild to moderate pain: acute postoperative pain, dental pain, headache, and musculoskeletal pain.
- Management of rheumatoid arthritis and osteoarthritis.
Contraindications (Do Not Use If…)
- Active peptic ulcer disease or history of recurrent gastrointestinal bleeding/perforation.
- Severe renal impairment or severe active kidney disease.
- Severe heart failure (NYHA Class IV) or coronary artery bypass graft (CABG) surgery.
- Third trimester of pregnancy (causes premature closure of ductus arteriosus).
- History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
Important Clinical Precautions & Warnings
- Take with meals or milk: always administer with food to minimize gastric mucosal irritation, nausea, and dyspepsia.
- Limit duration for acute pain: for primary dysmenorrhea, initiate at the onset of bleeding or cramps and limit treatment to 2 to 3 days per cycle; for general pain, do not exceed 7 consecutive days.
- Dual prostaglandin inhibition: unique among NSAIDs, mefenamic acid not only inhibits cyclooxygenase (COX-1/COX-2) enzymes to stop prostaglandin synthesis, but also directly blocks prostaglandin binding to its receptor on the uterine myometrium, producing rapid relief of menstrual cramps and reducing menstrual blood flow by up to 30-50%.
- Gastrointestinal bleeding and ulceration: serious GI toxicity can occur without warning symptoms; avoid in patients with active ulcers.
- Renal papillary necrosis: long-term use can cause renal papillary necrosis and acute interstitial nephritis; ensure adequate hydration.
- Autoimmune hemolytic anemia: prolonged continuous therapy (> 12 months) can induce Coombs-positive autoimmune hemolytic anemia; perform blood counts if anemia symptoms appear.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Safety and efficacy have not been established in children under 14 years for dysmenorrhea; pediatric suspension is used for fever under pediatric direction. Geriatric: Elderly patients are at high risk of fatal peptic ulcer complications and acute renal failure; use lowest effective dose.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Dyspepsia, epigastric pain, nausea, vomiting, diarrhea (most common gastrointestinal complaint), dizziness, and headache.
Serious Side Effects — Seek Urgent Medical Care
Gastrointestinal bleeding and perforation, acute renal failure, autoimmune hemolytic anemia, severe diarrhea requiring drug cessation, cardiovascular thrombosis, and Stevens-Johnson syndrome.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- Anticoagulants (warfarin, apixaban): significantly increases gastrointestinal bleeding risk; monitor INR closely.
- Lithium and methotrexate: decreases renal clearance, leading to dangerous lithium or methotrexate toxicity.
- ACE inhibitors / ARBs: diminishes antihypertensive response and accelerates renal function deterioration.
- Aspirin and other NSAIDs: additive ulceration risk; avoid combination.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Contraindicated starting at 20 weeks of pregnancy due to risk of oligohydramnios and fetal renal dysfunction; strictly contraindicated in the third trimester due to premature closure of the fetal ductus arteriosus and prolonged labor.
Lactation & Breastfeeding:
Use with caution — see notesTrace amounts of mefenamic acid are excreted into human milk. While short courses for post-cesarean pain are commonly prescribed, monitor infant for gastrointestinal side effects.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store tablets below 25°C (77°F). Protect from light and excessive moisture.
⏱️ Missed Dose Protocol:
Take with food as soon as remembered. If close to the next scheduled dose, skip and resume regular schedule. Do not take two doses at once.
Overdose produces acute gastrointestinal ulceration, vomiting, metabolic acidosis, renal failure, and seizures (grand mal convulsions are more frequent with mefenamic acid than other NSAIDs). Administer activated charcoal, IV fluids, and diazepam for seizures. Hemodialysis is ineffective.
Clinical Sources & Regulatory References
Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.
Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:
Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).
CDSCO Official Portal →U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.
Search FDA Labels on DailyMed →WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).
WHO Essential Medicines Registry →National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.
Query PubMed Studies for Mefenamic Acid →
4mg Clinical Pharmacology Team. Mefenamic Acid Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/mefenamic-acid/
